查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067529

免疫療法和細胞工程市場規模、佔有率和趨勢分析報告：按細胞類型、產品、適應症、應用、地區和細分市場預測（2026-2033 年）

Immune Cell Engineering Market Size, Share & Trends Analysis Report By Cell Type, By Product, By Disease Indication, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

免疫療法和細胞工程市場概覽

全球免疫療法市場預計到 2025 年將價值 41.9 億美元，預計到 2033 年將達到 143.1 億美元，2026 年至 2033 年的複合年成長率為 17.3%。

這一成長的驅動力包括：基因修飾免疫療法在癌症和自體免疫疾病治療中的應用日益廣泛，對細胞和基因療法研究的投資不斷增加，以及 CRISPR 和 CAR-T 細胞工程等技術的持續進步。

基因編輯與細胞治療技術的進步

基因編輯和細胞治療技術的進步推動了免疫細胞技術市場的發展，使得更精準、更個人化的免疫療法成為可能。 CRISPR-Cas9、TALENs等工具以及改進的病毒和非病毒遞送系統，促進了T細胞和NK細胞等免疫細胞的基因改造，從而增強了它們靶向癌細胞的能力。此外，CAR-T和TCR-T療法的創新提高了治療效果，減少了脫靶效應，並拓展了其在固體癌和自體免疫疾病的應用範圍。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場趨勢/前景
  • 市場動態
  • 個案研究的啟示
  • 商業環境分析

第4章：按單元格類型進行業務分析

  • 全球免疫療法市場：按細胞類型分類的波動分析
  • 全球免疫療法市場：按細胞類型分類的規模和趨勢分析，2021-2033年
  • T細胞
    • 全球T細胞市場估算與預測（2021-2033年）
  • NK細胞
    • 全球NK細胞市場估計與預測（2021-2033年）
  • 樹突狀細胞
    • 全球樹突細胞市場估計與預測（2021-2033）
  • 癌細胞
    • 全球癌細胞市場：估計與預測（2021-2033）
  • 幹細胞
    • 全球幹細胞市場估計與預測（2021-2033）
  • 其他
    • 其他全球市場的估計和預測（2021-2033 年）

第5章：依產品進行業務分析

  • 全球免疫療法市場：基於產品的波動分析
  • 全球免疫療法市場：基於產品的規模和趨勢分析，2021-2033年
  • 消耗品
    • 全球耗材市場估算與預測（2021-2033）
  • 裝置
    • 全球設備市場估算與預測（2021-2033）
  • 軟體
    • 全球軟體市場估算與預測（2021-2033）

第6章：依適用疾病進行業務分析

  • 全球免疫療法市場：按適用疾病分類的波動分析
  • 全球免疫療法市場：按適應症分類的規模和趨勢分析，2021-2033年
  • 心血管疾病
    • 全球心血管疾病市場估算與預測（2021-2033）
  • 呼吸系統疾病
    • 全球呼吸系統疾病市場估計與預測（2021-2033）
  • 感染疾病
    • 全球感染疾病市場估計與預測（2021-2033 年）
  • 癌症
    • 全球癌症市場估算與預測（2021-2033）
  • 神經系統疾病
    • 全球神經系統疾病市場估算與預測（2021-2033）
  • 其他
    • 其他全球市場的估計和預測（2021-2033 年）

第7章 依最終用途進行業務分析

  • 全球免疫療法市場：按最終用途分類的波動分析
  • 全球免疫療法市場：按最終用途分類的規模和趨勢分析，2021-2033年
  • 製藥和生物技術公司
    • 全球醫藥和生物技術市場估算和預測（2021-2033）
  • 醫院和診所
    • 全球醫院和診所市場估計與預測（2021-2033）
  • 學術和研究機構
    • 全球學術和研究機構市場估算和預測（2021-2033 年）
  • 其他
    • 其他全球市場的估計和預測（2021-2033 年）

第8章：免疫療法市場：區域、預測和趨勢分析（按細胞類型、產品類型、適應症疾病和最終用途分類）

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司分類
  • 策略規劃
  • 2025年公司市場分析
  • 公司簡介列表
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Lonza
    • Miltenyi BIoTec
    • Takara Bio Inc.
    • Sartorious AG
    • Agilent Technologies, Inc.
    • Bio-Techne
    • Bio-Rad Laboratories, Inc.
Product Code: GVR-4-68040-916-7

Immune Cell Engineering Market Summary

The global immune cell engineering market size was estimated at USD 4.19 billion in 2025 and is anticipated to reach USD 14.31 billion by 2033, growing at a CAGR of 17.3% from 2026 to 2033. This growth is driven by the increasing adoption of engineered immune cell therapies for cancer and autoimmune disease treatment, rising investments in cell and gene therapy research, and continuous advancements in technologies such as CRISPR and CAR-T cell engineering.

Advancements in Gene-Editing and Cell Therapy Technologies

Advancements in gene-editing and cell therapy technologies are driving the immune cell engineering market by enabling more precise and personalized immunotherapies. Tools such as CRISPR-Cas9, TALENs, and improved viral and non-viral delivery systems enhance the genetic modification of immune cells, such as T cells and NK cells, thereby improving their ability to target cancer cells. In addition, innovations in CAR-T and TCR-T therapies are increasing treatment efficacy, reducing off-target effects, and expanding applications to solid tumors and autoimmune diseases.

Global Immune Cell Engineering Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global immune cell engineering market report based on cell type, product, disease indication, end-use, and region:

  • Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
  • T Cells
  • NK Cells
  • Dendritic Cells
  • Tumor Cells
  • Stem Cells
  • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables
  • Instruments
  • Software
  • Disease Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Infectious Diseases
  • Cancer
  • Neurological Diseases
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Cell Type
    • 1.2.2. Product
    • 1.2.3. Disease Indication
    • 1.2.4. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Impact Analysis
      • 3.3.1.1. Advancements in gene-editing and cell therapy technologies
      • 3.3.1.2. Expanding clinical trials for engineered immune cell therapies
      • 3.3.1.3. Rising prevalence of cancer and chronic diseases
      • 3.3.1.4. Increasing adoption of personalized medicine
    • 3.3.2. Market Restraint Impact Analysis
      • 3.3.2.1. High manufacturing and development costs
      • 3.3.2.2. Safety and clinical limitations
    • 3.3.3. Market Opportunity Analysis
    • 3.3.4. Market Challenge Analysis
  • 3.4. Case Study Insights
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTLE Analysis
    • 3.5.2. PORTER'S Five Forces Analysis

Chapter 4. Cell Type Business Analysis

  • 4.1. Cell Type Segment Dashboard
  • 4.2. Global Immune Cell Engineering Market Cell Type, Movement Analysis
  • 4.3. Global Immune Cell Engineering Market Size & Trend Analysis, by Cell Type, 2021 to 2033 (USD Million)
  • 4.4. T Cells
    • 4.4.1. Global T Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. NK Cells
    • 4.5.1. Global NK Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Dendritic Cells
    • 4.6.1. Global Dendritic Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Tumor Cells
    • 4.7.1. Global Tumor Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Stem Cells
    • 4.8.1. Global Stem Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Product Segment Dashboard
  • 5.2. Global Immune Cell Engineering Market Product, Movement Analysis
  • 5.3. Global Immune Cell Engineering Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Consumables
    • 5.4.1. Global Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Instruments
    • 5.5.1. Global Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Software
    • 5.6.1. Global Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Disease Indication Business Analysis

  • 6.1. Disease Indication Segment Dashboard
  • 6.2. Global Immune Cell Engineering Market Disease Indication, Movement Analysis
  • 6.3. Global Immune Cell Engineering Market Size & Trend Analysis, by Disease Indication, 2021 to 2033 (USD Million)
  • 6.4. Cardiovascular Diseases
    • 6.4.1. Global Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Respiratory Diseases
    • 6.5.1. Global Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Infectious Diseases
    • 6.6.1. Global Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Cancer
    • 6.7.1. Global Cancer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Neurological Diseases
    • 6.8.1. Global Neurological Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Others
    • 6.9.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Immune Cell Engineering Market End Use, Movement Analysis
  • 7.3. Global Immune Cell Engineering Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Global Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Immune Cell Engineering Market: Regional Estimates and Trend Analysis, by Cell Type, Product, Disease Indication & End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. North America Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Immune Cell Engineering Market, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Immune Cell Engineering Market, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Immune Cell Engineering Market, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Immune Cell Engineering Market, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Immune Cell Engineering Market, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Immune Cell Engineering Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2025
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Danaher Corporation
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Lonza
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Miltenyi Biotec
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Takara Bio Inc.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Sartorious AG
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Agilent Technologies, Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Bio-Techne
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Bio-Rad Laboratories, Inc.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 4. Global Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 5. Global Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 6. Global Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 7. Global Immune Cell Engineering Market, by Region, 2021 - 2033 (USD Million)
  • Table 8. North America Immune Cell Engineering Market, by Country, 2021 - 2033 (USD Million)
  • Table 9. North America Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 10. North America Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 11. North America Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 12. North America Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 13. U.S. Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 14. U.S. Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 15. U.S Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 16. U.S. Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 17. Canada Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 18. Canada Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 19. Canada Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 20. Canada Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 21. Mexico Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 22. Mexico Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 23. Mexico Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 24. Mexico Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 25. Europe Immune Cell Engineering Market, by Country, 2021 - 2033 (USD Million)
  • Table 26. Europe Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 27. Europe Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 28. Europe Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 29. Europe Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30. Germany Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 31. Germany Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 32. Germany Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 33. Germany Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 34. UK Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 35. UK Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 36. UK Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 37. UK Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 38. France Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 39. France Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 40. France Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 41. France Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42. Italy Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 43. Italy Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 44. Italy Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 45. Italy Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 46. Spain Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 47. Spain Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 48. Spain Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 49. Spain Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 50. Denmark Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 51. Denmark Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 52. Denmark Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 53. Denmark Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 54. Norway Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 55. Norway Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 56. Norway Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 57. Norway Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 58. Sweden Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 59. Sweden Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 60. Sweden Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 61. Sweden Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 62. Asia Pacific Immune Cell Engineering Market, by Country, 2021 - 2033 (USD Million)
  • Table 63. Asia Pacific Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 64. Asia Pacific Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 65. Asia Pacific Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 66. Asia Pacific Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 67. China Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 68. China Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 69. China Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 70. China Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 71. Japan Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 72. Japan Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 73. Japan Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 74. Japan Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 75. India Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 76. India Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 77. India Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 78. India Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 79. South Korea Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 80. South Korea Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 81. South Korea Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 82. South Korea Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 83. Australia Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 84. Australia Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 85. Australia Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 86. Australia Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87. Thailand Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 88. Thailand Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 89. Thailand Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 90. Thailand Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 91. Latin America Immune Cell Engineering Market, by Country, 2021 - 2033 (USD Million)
  • Table 92. Latin America Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 93. Latin America Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 94. Latin America Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 95. Latin America Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 96. Brazil Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 97. Brazil Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 98. Brazil Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 99. Brazil Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 100. Argentina Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 101. Argentina Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 102. Argentina Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 103. Argentina Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 104. Middle East and Africa Immune Cell Engineering Market, by Country, 2021 - 2033 (USD Million)
  • Table 105. Middle East and Africa Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 106. Middle East and Africa Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 107. Middle East and Africa Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 108. Middle East and Africa Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 109. South Africa Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 110. South Africa Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 111. South Africa Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 112. South Africa Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 113. Saudi Arabia Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 114. Saudi Arabia Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 115. Saudi Arabia Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 116. Saudi Arabia Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 117. UAE Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 118. UAE Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 119. UAE Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 120. UAE Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)
  • Table 121. Kuwait Immune Cell Engineering Market, by Cell Type, 2021 - 2033 (USD Million)
  • Table 122. Kuwait Immune Cell Engineering Market, by Product, 2021 - 2033 (USD Million)
  • Table 123. Kuwait Immune Cell Engineering Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 124. Kuwait Immune Cell Engineering Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Immune cell engineering market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validation & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 Immune cell engineering market: Cell Type outlook key takeaways
  • Fig. 19 Immune cell engineering market: Cell Type movement analysis
  • Fig. 20 T Cells market, 2021 - 2033 (USD Million)
  • Fig. 21 NK Cells market, 2021 - 2033 (USD Million)
  • Fig. 22 Dendritic Cells market, 2021 - 2033 (USD Million)
  • Fig. 23 Tumor Cells market, 2021 - 2033 (USD Million)
  • Fig. 24 Stem Cells market, 2021 - 2033 (USD Million)
  • Fig. 25 Others market, 2021 - 2033 (USD Million)
  • Fig. 26 Immune cell engineering market: Product outlook key takeaways
  • Fig. 27 Immune cell engineering market: Product movement analysis
  • Fig. 28 Consumables market, 2021 - 2033 (USD Million)
  • Fig. 29 Instruments market, 2021 - 2033 (USD Million)
  • Fig. 30 Software market, 2021 - 2033 (USD Million)
  • Fig. 31 Immune cell engineering market: Disease indication outlook key takeaways
  • Fig. 32 Immune cell engineering market: Disease indication movement analysis
  • Fig. 33 Cardiovascular Diseases market, 2021 - 2033 (USD Million)
  • Fig. 34 Respiratory Diseases market, 2021 - 2033 (USD Million)
  • Fig. 35 Infectious Diseases market, 2021 - 2033 (USD Million)
  • Fig. 36 Cancer market, 2021 - 2033 (USD Million)
  • Fig. 37 Neurological Diseases market, 2021 - 2033 (USD Million)
  • Fig. 38 Others market, 2021 - 2033 (USD Million)
  • Fig. 39 Immune cell engineering market: End Use outlook key takeaways
  • Fig. 40 Immune cell engineering market: End Use movement analysis
  • Fig. 41 Pharmaceutical & Biotechnology Companies market, 2021 - 2033 (USD Million)
  • Fig. 42 Hospitals & Clinics market, 2021 - 2033 (USD Million)
  • Fig. 43 Academic & Research Institutes market, 2021 - 2033 (USD Million)
  • Fig. 44 Others market, 2021 - 2033 (USD Million)
  • Fig. 45 Regional marketplace outlook, 2025 & 2033 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 North America immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 U.S. immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Canada immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Mexico immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Europe immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Germany immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Spain immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Denmark immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Norway immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 71 Asia Pacific immune cell engineering market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 China immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 India immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Korea immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Australia immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Thailand immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Latin America immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Argentina immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 MEA immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Africa immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Saudi Arabia immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 UAE immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Kuwait immune cell engineering market estimates and forecasts, 2021 - 2033 (USD Million)